These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17459651)

  • 1. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
    Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
    Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antileishmanial activity of five 2- or 3- quinolines by enyne group].
    Seck M; Desrivot J; Bories C; Loiseau P; Franck X; Hocquemiller R; Figadere B; Peyrat JF; Provot O; Brion JD; Alami M
    Dakar Med; 2005; 50(3):172-5. PubMed ID: 17633005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials.
    Vieira NC; Herrenknecht C; Vacus J; Fournet A; Bories C; Figadère B; Espindola LS; Loiseau PM
    Biomed Pharmacother; 2008 Dec; 62(10):684-9. PubMed ID: 18849137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
    Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
    Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antileishmanial efficacy of a new nitrilquinoline against Leishmania donovani.
    Nakayama H; Desrivot J; Bories C; Franck X; Figadère B; Hocquemiller R; Fournet A; Loiseau PM
    Biomed Pharmacother; 2007; 61(2-3):186-8. PubMed ID: 17360145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
    Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
    Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
    Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
    Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of novel substituted quinazoline derivatives as antileishmanial agents.
    Agarwal KC; Sharma V; Shakya N; Gupta S
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5474-7. PubMed ID: 19692240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro antileishmanial activity of 5-substituted-2'-deoxyuridine derivatives.
    Peyron C; Benhida R; Bories C; Loiseau PM
    Bioorg Chem; 2005 Dec; 33(6):439-47. PubMed ID: 16168460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a SPE/HPLC/DAD method for the determination of antileishmanial 2-substituted quinolines and metabolites in rat plasma.
    Desrivot J; Moussa F; Champy P; Fournet A; Figadère B; Herrenknecht C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):230-8. PubMed ID: 17499564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
    Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
    Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of synthetic tetrahydroindeno[2,1-c]quinolines on Leishmania mexicana.
    Hernández-Chinea C; Carbajo E; Sojo F; Arvelo F; Kouznetsov VV; Romero-Bohórquez AR; Romero PJ
    Parasitol Int; 2015 Dec; 64(6):479-83. PubMed ID: 26148815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 2-substituted trifluoromethylquinolines for the evaluation of leishmanicidal activity.
    Dade J; Provot O; Moskowitz H; Mayrargue J; Prina E
    Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):480-3. PubMed ID: 11310679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
    Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
    Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro.
    Heurtault B; Legrand P; Mosqueira V; Devissaguet JP; Barratt G; Bories C
    Ann Trop Med Parasitol; 2001 Jul; 95(5):529-33. PubMed ID: 11487374
    [No Abstract]   [Full Text] [Related]  

  • 17. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
    Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
    Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
    Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
    Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antileishmanial activities of novel 3-substituted quinolines.
    Tempone AG; da Silva AC; Brandt CA; Martinez FS; Borborema SE; da Silveira MA; de Andrade HF
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1076-80. PubMed ID: 15728905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antiprotozoal activity of some new synthetic substituted quinoxalines.
    Hui X; Desrivot J; Bories C; Loiseau PM; Franck X; Hocquemiller R; Figadère B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):815-20. PubMed ID: 16309903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.